Olynyk J, Grainger R, Currie H, Ramm L, Ramm G
Sci Rep. 2023; 13(1):7775.
PMID: 37179448
PMC: 10183001.
DOI: 10.1038/s41598-023-35028-4.
Barton J, Barton J, Acton R
Hereditas. 2022; 159(1):25.
PMID: 35659379
PMC: 9169309.
DOI: 10.1186/s41065-022-00237-w.
Porto G, Cruz E, Teles M, de Sousa M
Pharmaceuticals (Basel). 2019; 12(3).
PMID: 31443397
PMC: 6789554.
DOI: 10.3390/ph12030122.
Carlson J, Olsson S
EJIFCC. 2018; 13(2):31-38.
PMID: 30429720
PMC: 6232860.
Hollerer I, Bachmann A, Muckenthaler M
Haematologica. 2017; 102(5):809-817.
PMID: 28280078
PMC: 5477599.
DOI: 10.3324/haematol.2016.160432.
Histocompatibility antigens and haemochromatosis in Ireland.
McCarthy D, FitzGerald G, OConnell L, Waters J, Watt D, Stevens F
Ir J Med Sci. 2016; 148(1):168.
PMID: 27517412
DOI: 10.1007/BF02938074.
Autoimmune Conditions in 235 Hemochromatosis Probands with HFE C282Y Homozygosity and Their First-Degree Relatives.
Barton J, Barton J
J Immunol Res. 2015; 2015:453046.
PMID: 26504855
PMC: 4609477.
DOI: 10.1155/2015/453046.
HFE gene: Structure, function, mutations, and associated iron abnormalities.
Barton J, Edwards C, Acton R
Gene. 2015; 574(2):179-92.
PMID: 26456104
PMC: 6660136.
DOI: 10.1016/j.gene.2015.10.009.
Some medical applications of the oxford scanning proton microprobe.
Vaux D, Grime G, Watt F
Biol Trace Elem Res. 2013; 13(1):115-33.
PMID: 24254670
DOI: 10.1007/BF02796626.
The long history of iron in the Universe and in health and disease.
Sheftel A, Mason A, Ponka P
Biochim Biophys Acta. 2011; 1820(3):161-87.
PMID: 21856378
PMC: 3258305.
DOI: 10.1016/j.bbagen.2011.08.002.
Iron storage disease: facts, fiction and progress.
Beutler E
Blood Cells Mol Dis. 2007; 39(2):140-7.
PMID: 17540589
PMC: 2030637.
DOI: 10.1016/j.bcmd.2007.03.009.
Iron Overload (with Attention to Genetic Testing and Diagnosis/Management of HFE Wild Type Patients).
Siddaiah N, Kowdley K
Curr Treat Options Gastroenterol. 2006; 9(6):447-55.
PMID: 17181986
DOI: 10.1007/s11938-006-0001-z.
Molecular insights into the pathogenesis of hereditary haemochromatosis.
Pietrangelo A
Gut. 2006; 55(4):564-8.
PMID: 16531535
PMC: 1856183.
DOI: 10.1136/gut.2005.078063.
Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management.
Nelson J, Kowdley K
Curr Gastroenterol Rep. 2005; 7(1):71-80.
PMID: 15701302
DOI: 10.1007/s11894-005-0069-y.
The origin and spread of the HFE-C282Y haemochromatosis mutation.
Distante S, Robson K, Graham-Campbell J, Arnaiz-Villena A, Brissot P, Worwood M
Hum Genet. 2004; 115(4):269-79.
PMID: 15290237
DOI: 10.1007/s00439-004-1152-4.
Genetic analysis of idiopathic hemochromatosis using both qualitative (disease status) and quantitative (serum iron) information.
Lalouel J, Le Mignon L, Simon M, Fauchet R, BOUREL M, Rao D
Am J Hum Genet. 1985; 37(4):700-18.
PMID: 9556659
PMC: 1684619.
Targeted disruption of the HFE gene.
Beutler E
Proc Natl Acad Sci U S A. 1998; 95(5):2033-4.
PMID: 9482831
PMC: 33839.
DOI: 10.1073/pnas.95.5.2033.
A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium.
Gut. 1998; 41(6):841-4.
PMID: 9462220
PMC: 1891611.
DOI: 10.1136/gut.41.6.841.
HLA-H and associated proteins in patients with hemochromatosis.
Beutler E, West C, Gelbart T
Mol Med. 1997; 3(6):397-402.
PMID: 9234244
PMC: 2230203.
Global prevalence of putative haemochromatosis mutations.
Merryweather-Clarke A, Pointon J, Shearman J, Robson K
J Med Genet. 1997; 34(4):275-8.
PMID: 9138148
PMC: 1050911.
DOI: 10.1136/jmg.34.4.275.
